Director, Life Cycle Management and Competitive Differentiation, Diabetes Job
Company Name:
Janssen Global Services, LLC (6085)
Raritan, NJ, US
Johnson & Johnson companies are equal opportunity employers.
Director, Life Cycle Management and Competitive Differentiation, Diabetes-00000IXB
Description
Janssen Global Services, a member of Johnson & Johnson?s family of companies, is currently recruiting for a, Director, Life Cycle Management (LCM) and Competitive Differentiation, Diabetes, within the CVM TA., to be located in Raritan, NJ, or High Wycombe, UK.
Janssen Pharmaceutical Companies of Johnson & Johnson is the fastest growing among the top 10 global pharmaceutical companies, with 2012 reported sales of $25.4 Billion (+6.8% vs. prior year), and 2013 sales growth through Q2 reported at over 11% vs. prior year.
Janssen has launched 15 new products in the past 10 years, including 4 new products from 2004 to 2008, and 11 new products from 2009 through Q2, 2013. Janssen is committed to sourcing the best science in the world ? Internally and externally, thereby delivering growth and enabling further R&D investment.
Janssen is committed to building on this strong momentum by
- Continuing to make a difference through transformational medical innovation
- Continuously transforming our business with leading science and best-in-class commercial capabilities
- Enhancing our pipeline to deliver the next wave of growth.
Five end-to-end Therapeutic Areas (TAs) remain the foundation of the Janssen organizational model. The five TAs are: Cardiovascular and Metabolism (CVM), Immunology, Infectious Disease, Neuroscience, and Oncology. The TA model, with end-to-end strategy and development housed in each TA team, enables Janssen to attract top talent, gain deep scientific and market insights in each TA, increase pipeline productivity, and sustain growth by empowering TA teams to operate with speed, agility, and deep knowledge in their respective TA space.
Cardiovascular and Metabolism (CVM) TA
In light of the enormous global unmet medical need in CVM, and with the successful launch of Janssen products in 2011 and 2013, CVM is an important area of growth and market leadership opportunity for Janssen.
Beyond currently-approved therapies, Janssen is committed to transforming the treatment of diabetes patients through transformational medical innovation, including sourcing the world?s best science, both internally and externally. Current diabetes pipeline work focuses in two areas. First, novel therapies to prevent disease progression, including novel partnerships and internal development programs in Beta cell preservation and proliferation, Beta cell replacement, and reversal of insulin resistance. Second, innovative approaches to target diabetic complications, including research in end-organ protection.
This role will be accountable for leading Janssen Global Commercial Strategy in Life Cycle Management and Competitive Differentiation for current and future Janssen Diabetes portfolio. Core areas of responsibility include:
- Synthesize market analytics assessments, product performance data, clinical data, and primary and secondary market research to deliver insights that inform and drive superior Life Cycle Management choices for Janssen?s current and future diabetes portfolio. Such choices include, but are not limited to:
- Prioritization of LCM research studies based on clinical and commercial needs
- Choices related to LCM study design and target end points
- (In partnership with Medical Affairs) data dissemination and publication plans related to LCM studies
- Collaborate with R&D, Business Development, and regional commercial partners to proactively identify and bring forward recommendations for future/ongoing LCM study needs
- Synthesize market analytics assessments, product performance data, clinical data, and primary and secondary market research to deliver insights that inform and drive superior competitive positioning choices for current products and Janssen?s future diabetes portfolio
Experiences Gained
This position provides an exceptional career advancement opportunity for the right candidate. The role offers significant organizational exposure across Janssen TA leadership, and significant experiences gained in the following areas:
- Global product and life cycle management
- Global disease area commercial leadership
- Managing complexity in multi- functional and global environment
- Building new and innovative marketing approaches
- Deeper understanding of R&D and and clinical trial development processes
- Long range Strategic Thinking skills and Global mindset
Qualifications
A minimum of 5 years of pharmaceutical commercial and strategic experience is required. A minimum of Bachelor?s Degree in a relevant area is required. An MBA or relevant advanced degree is strongly preferred.
The successful candidate will have demonstrated a strong track record of success in the following areas:
- Relevant commercial experience preferably managing/leading in-line local/regional marketing teams, with an excellent track record of delivering commercial growth ahead of relevant market rates, through innovative and insightful marketing approaches
- Leadership ability to successfully work across functional and geographic boundaries (preferably across multiple markets and products).
- Proven strategic thinking and strategic marketing skills across product stages end-to-end, especially launch and life cycle management.
- Strong learning agility to quickly establish a sounds understanding of diabetes sciences and relevant product-specific clinical data, and ability to effectively influence LCM and competitive strategies based on insights and foresights to future scientific direction in diabetes and CVM
- A successful track record in partnering and collaborating across multiple functions i.e. marketing, market access, medical affairs, R&D, regulatory, and operations
- Ability to operate globally and locally and influence in without direct-line reporting authority
The position will be based in Raritan, NJ, or High Wycombe, UK, and require occasional international travel.
Primary Location:
North America-United States-New Jersey-Raritan
Other Locations:
Europe/Middle East/Africa-United Kingdom-England-High Wycombe
Organization:
Janssen Global Services, LLC (6085)
Job Function:
Marketing
Certain sites within the Johnson & Johnson Family of Companies participate in E-Verify as appropriate in accordance with Company guidelines and federal or state law. To learn more about the government sponsored program and to see a list of the sites that are currently enrolled, please click here.
Johnson and Johnson Family of Companies are equal opportunity employers, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, protected veteran status, or disability status, or any other characteristic protected by law.
EEO is the Law
EEO is the Law GINA SupplementEstimated Salary: $20 to $28 per hour based on qualifications.
Janssen Global Services, LLC (6085)
Raritan, NJ, US
Johnson & Johnson companies are equal opportunity employers.
Director, Life Cycle Management and Competitive Differentiation, Diabetes-00000IXB
Description
Janssen Global Services, a member of Johnson & Johnson?s family of companies, is currently recruiting for a, Director, Life Cycle Management (LCM) and Competitive Differentiation, Diabetes, within the CVM TA., to be located in Raritan, NJ, or High Wycombe, UK.
Janssen Pharmaceutical Companies of Johnson & Johnson is the fastest growing among the top 10 global pharmaceutical companies, with 2012 reported sales of $25.4 Billion (+6.8% vs. prior year), and 2013 sales growth through Q2 reported at over 11% vs. prior year.
Janssen has launched 15 new products in the past 10 years, including 4 new products from 2004 to 2008, and 11 new products from 2009 through Q2, 2013. Janssen is committed to sourcing the best science in the world ? Internally and externally, thereby delivering growth and enabling further R&D investment.
Janssen is committed to building on this strong momentum by
- Continuing to make a difference through transformational medical innovation
- Continuously transforming our business with leading science and best-in-class commercial capabilities
- Enhancing our pipeline to deliver the next wave of growth.
Five end-to-end Therapeutic Areas (TAs) remain the foundation of the Janssen organizational model. The five TAs are: Cardiovascular and Metabolism (CVM), Immunology, Infectious Disease, Neuroscience, and Oncology. The TA model, with end-to-end strategy and development housed in each TA team, enables Janssen to attract top talent, gain deep scientific and market insights in each TA, increase pipeline productivity, and sustain growth by empowering TA teams to operate with speed, agility, and deep knowledge in their respective TA space.
Cardiovascular and Metabolism (CVM) TA
In light of the enormous global unmet medical need in CVM, and with the successful launch of Janssen products in 2011 and 2013, CVM is an important area of growth and market leadership opportunity for Janssen.
Beyond currently-approved therapies, Janssen is committed to transforming the treatment of diabetes patients through transformational medical innovation, including sourcing the world?s best science, both internally and externally. Current diabetes pipeline work focuses in two areas. First, novel therapies to prevent disease progression, including novel partnerships and internal development programs in Beta cell preservation and proliferation, Beta cell replacement, and reversal of insulin resistance. Second, innovative approaches to target diabetic complications, including research in end-organ protection.
This role will be accountable for leading Janssen Global Commercial Strategy in Life Cycle Management and Competitive Differentiation for current and future Janssen Diabetes portfolio. Core areas of responsibility include:
- Synthesize market analytics assessments, product performance data, clinical data, and primary and secondary market research to deliver insights that inform and drive superior Life Cycle Management choices for Janssen?s current and future diabetes portfolio. Such choices include, but are not limited to:
- Prioritization of LCM research studies based on clinical and commercial needs
- Choices related to LCM study design and target end points
- (In partnership with Medical Affairs) data dissemination and publication plans related to LCM studies
- Collaborate with R&D, Business Development, and regional commercial partners to proactively identify and bring forward recommendations for future/ongoing LCM study needs
- Synthesize market analytics assessments, product performance data, clinical data, and primary and secondary market research to deliver insights that inform and drive superior competitive positioning choices for current products and Janssen?s future diabetes portfolio
Experiences Gained
This position provides an exceptional career advancement opportunity for the right candidate. The role offers significant organizational exposure across Janssen TA leadership, and significant experiences gained in the following areas:
- Global product and life cycle management
- Global disease area commercial leadership
- Managing complexity in multi- functional and global environment
- Building new and innovative marketing approaches
- Deeper understanding of R&D and and clinical trial development processes
- Long range Strategic Thinking skills and Global mindset
Qualifications
A minimum of 5 years of pharmaceutical commercial and strategic experience is required. A minimum of Bachelor?s Degree in a relevant area is required. An MBA or relevant advanced degree is strongly preferred.
The successful candidate will have demonstrated a strong track record of success in the following areas:
- Relevant commercial experience preferably managing/leading in-line local/regional marketing teams, with an excellent track record of delivering commercial growth ahead of relevant market rates, through innovative and insightful marketing approaches
- Leadership ability to successfully work across functional and geographic boundaries (preferably across multiple markets and products).
- Proven strategic thinking and strategic marketing skills across product stages end-to-end, especially launch and life cycle management.
- Strong learning agility to quickly establish a sounds understanding of diabetes sciences and relevant product-specific clinical data, and ability to effectively influence LCM and competitive strategies based on insights and foresights to future scientific direction in diabetes and CVM
- A successful track record in partnering and collaborating across multiple functions i.e. marketing, market access, medical affairs, R&D, regulatory, and operations
- Ability to operate globally and locally and influence in without direct-line reporting authority
The position will be based in Raritan, NJ, or High Wycombe, UK, and require occasional international travel.
Primary Location:
North America-United States-New Jersey-Raritan
Other Locations:
Europe/Middle East/Africa-United Kingdom-England-High Wycombe
Organization:
Janssen Global Services, LLC (6085)
Job Function:
Marketing
Certain sites within the Johnson & Johnson Family of Companies participate in E-Verify as appropriate in accordance with Company guidelines and federal or state law. To learn more about the government sponsored program and to see a list of the sites that are currently enrolled, please click here.
Johnson and Johnson Family of Companies are equal opportunity employers, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, protected veteran status, or disability status, or any other characteristic protected by law.
EEO is the Law
EEO is the Law GINA SupplementEstimated Salary: $20 to $28 per hour based on qualifications.
|
|
 | |
